The emerging treatment of tirzepatide peptide represents a major advance in the care of type 2 diabetes. Different to existing drugs, tirzepatide affects multiple pathways – glucagon-like peptide-1 (GLP-1) and the https://tirzepatidepeptide308522.oblogation.com/40814688/tirzepatide-peptide-a-new-frontier-in-diabetes-treatment